Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Semaglutide

Semaglutide induced hyposalivation

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mawardi HH, et al. Semaglutide-associated hyposalivation: A report of case series. Medicine 102: 1-4, No. 52, Dec 2023. Available from: URL: https://dx.doi.org/10.1097/MD.0000000000036730 Mawardi HH, et al. Semaglutide-associated hyposalivation: A report of case series. Medicine 102: 1-4, No. 52, Dec 2023. Available from: URL: https://dx.doi.org/10.1097/MD.0000000000036730
Metadaten
Titel
Semaglutide
Semaglutide induced hyposalivation
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55352-0

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Lorazepam

Case report

Prednisone

Case report

Elasomeran

Case report

Pregabalin

Case report

Multiple drugs